Search research articles
Contact Us
Filters
Showing results (91-100 of 101) with videos related to
Page
of 11
Sort By:
Plos Pathogens
|
August 21, 2023
The small non-coding RNA B11 regulates multiple facets of Mycobacterium abscessus virulence
Michal Bar-Oz, Maria Carla Martini, Maria Natalia Alonso, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
May 16, 2023
Safety and Efficacy of Baseline Antiplatelet Treatment in Patients Undergoing Mechanical Thrombectomy for Ischemic Stroke: Antiplatelets Before Mechanical Thrombectomy
Tomas Klail, Petra Sedova, Jan F Vinklarek, et al.
Blood
|
February 28, 2014
NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML
Sophia Adamia, Michal Bar-Natan, Benjamin Haibe-Kains, et al.
Stroke
|
May 15, 2020
Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups
Hans-Christoph Diener, Ralph L Sacco, J Donald Easton, et al.
Neurology
|
September 29, 2020
Thrombectomy vs medical management in low NIHSS acute anterior circulation stroke
Ondrej Volny, Charlotte Zerna, Ales Tomek, et al.
Blood
|
August 18, 2016
Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent
Michael Xiang, Haesook Kim, Vincent T Ho, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2009
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia
Akinori Yoda, Yuka Yoda, Sabina Chiaretti, et al.
Plos One
|
December 14, 2021
Nationwide screening for Fabry disease in unselected stroke patients
Aleš Tomek, Reková Petra, Jaroslava Paulasová Schwabová, et al.
Blood Advances
|
October 31, 2025
Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Asparaginase-Treated ALL
Daniela R Anderson, Radhika Gangaraju, Wafik G Sedhom, et al.
Leukemia
|
January 13, 2019
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
Detlef Haase, Kristen E Stevenson, Donna Neuberg, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 101) with videos related to
Sort By:
Page
of 11
Plos Pathogens
|
August 21, 2023
The small non-coding RNA B11 regulates multiple facets of Mycobacterium abscessus virulence
Michal Bar-Oz, Maria Carla Martini, Maria Natalia Alonso, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
May 16, 2023
Safety and Efficacy of Baseline Antiplatelet Treatment in Patients Undergoing Mechanical Thrombectomy for Ischemic Stroke: Antiplatelets Before Mechanical Thrombectomy
Tomas Klail, Petra Sedova, Jan F Vinklarek, et al.
Blood
|
February 28, 2014
NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML
Sophia Adamia, Michal Bar-Natan, Benjamin Haibe-Kains, et al.
Stroke
|
May 15, 2020
Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups
Hans-Christoph Diener, Ralph L Sacco, J Donald Easton, et al.
Neurology
|
September 29, 2020
Thrombectomy vs medical management in low NIHSS acute anterior circulation stroke
Ondrej Volny, Charlotte Zerna, Ales Tomek, et al.
Blood
|
August 18, 2016
Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent
Michael Xiang, Haesook Kim, Vincent T Ho, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2009
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia
Akinori Yoda, Yuka Yoda, Sabina Chiaretti, et al.
Plos One
|
December 14, 2021
Nationwide screening for Fabry disease in unselected stroke patients
Aleš Tomek, Reková Petra, Jaroslava Paulasová Schwabová, et al.
Blood Advances
|
October 31, 2025
Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Asparaginase-Treated ALL
Daniela R Anderson, Radhika Gangaraju, Wafik G Sedhom, et al.
Leukemia
|
January 13, 2019
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
Detlef Haase, Kristen E Stevenson, Donna Neuberg, et al.
Page
of 11